Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Pinto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1988 - 1991
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1983 - 1986
Yale School of MedicineClass of 1983
Certifications & Licensure
CA State Medical License 1988 - 2026
OH State Medical License 1986 - 1988
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer Start of enrollment: 1995 May 30
- Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer Start of enrollment: 1996 Jun 01
- Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers Start of enrollment: 1998 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- MDM2 inhibition is associated with the emergence of TP53-altered clonal hematopoiesis.Vishesh Khanna, Gohar Eslami, Rochelle Reyes, Robert Diep, Sebastian Fernandez-Pol
NPJ Precision Oncology. 2025-02-03 - NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025.A Dimitrios Colevas, Anthony J Cmelak, David G Pfister, Sharon Spencer, Douglas Adkins
Journal of the National Comprehensive Cancer Network. 2025-02-01 - Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (...M Margaret Kemeny, Fengmin Zhao, Arlene A Forastiere, Paul Catalano, Stanley R Hamilton
Annals of Surgical Oncology. 2023-02-01
Grant Support
- Exploiting Tumor Hypoxia--Does IT Work ClinicallyNational Cancer Institute1996–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
